Christien Kluwe, MD
Basic profileThe University of Texas at San Antonio Health Science Center
Christien Kluwe is an Oncology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 32 publications with 560 citations (h-index 10).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7979 Wurzbach Rd Fl 2
San Antonio, TX 782294427
Telephone
210-450-6490Provider last certified this registry record 26 Jul 2023.
Industry payments
8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Siemens Medical Solutions USA, Inc.Program year20257 payments
- Teleflex LLCProgram year20258 payments
- Globus Medical, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
37.3%Benzodiazepine21.3%Midazolam hydrochloride100%Part B, office-administered≥11 patientsOpioid Agonist16%Hydromorphone100%Part B, office-administered≥11 patientsCancer & immunology
32%Gonadotropin Releasing Hormone Receptor Antagonist32%Orgovyx100%Part D<11 patientsGenitourinary & hormones
30.7%alpha-Adrenergic Blocker30.7%Tamsulosin Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Preoperative Radiotherapy with or without Chemotherapy in the Management of Endometrial Cancer, Outcomes of Disease Control and Toxicity
International Journal of Radiation Oncology*Biology*Physics
2025 - Utilizing of a Dedicated Radiation Oncology Documentation Software Designed with Physician Input and Note Completion Times
International Journal of Radiation Oncology*Biology*Physics
2024 - Comparison of first-line radiosurgery for small-cell and non-small cell lung cancer brain metastases (CROSS-FIRE)
JNCI Journal of the National Cancer Institute
2023 - Triggering daily online adaptive radiotherapy in the pelvis: Dosimetric effects and procedural implications of trigger parameter‐value selection
Journal of Applied Clinical Medical Physics
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Marcos Restrepo, MD, MSc
The University of Texas at San Antonio Health Science Center
Robert Brzyski, MD
The University of Texas at San Antonio Health Science Center
Devjit Tripathy, MD
The University of Texas at San Antonio Health Science Center
Robert Svatek, MD
The University of Texas at San Antonio Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”